{"id":"W2282340687","doi":"10.1200/jco.2009.27.15_suppl.5098","title":"Failure of initial VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC): What next?","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Sunitinib; Sorafenib; Temsirolimus; Everolimus; Bevacizumab; Internal medicine; Targeted therapy; Renal cell carcinoma; Oncology; Axitinib; Population; Cancer; Hepatocellular carcinoma; PI3K/AKT/mTOR pathway; Chemotherapy; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728534,0.0001088534,0.0006759849,0.0005659342,0.0003010302,0.001024137,0.0006673348,0.0005185491,0.001343109],"category_scores_gemma":[0.004037161,0.00009811587,0.0003279471,0.001375995,0.0005174882,0.0008347267,0.0002701431,0.000396441,0.0003415461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001719456,"about_ca_system_score_gemma":0.001931813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02267829,"about_ca_topic_score_gemma":0.03722529,"domain_scores_codex":[0.9993054,0.0001085158,0.00009790678,0.0001125929,0.0002322885,0.0001433351],"domain_scores_gemma":[0.9952946,0.0009385778,0.002382432,0.0001625562,0.0007526369,0.0004691828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001492949,0.00002138,0.9807456,0.0000778086,0.00004005186,0.0001479416,0.00006154955,0.00008973446,0.0001189537,0.00003933784,0.0008498623,0.01765854],"study_design_scores_gemma":[0.00001873982,0.0001461259,0.9945562,0.0001761833,0.00006812348,0.001637016,0.0004784372,0.0004627939,0.0002095403,0.00009818962,0.002137529,0.0000112306],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.9767938,0.0169178,0.0003086602,0.002824362,0.00005204659,0.00001968185,0.001029479,0.00001614241,0.002038083],"genre_scores_gemma":[0.9960248,0.002858429,0.0001345584,0.000239861,0.0001035402,0.000006043243,0.0005365022,0.000003024624,0.00009324592],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.02267829,"threshold_uncertainty_score":0.04509258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1437245327496539,"score_gpt":0.4492427574818181,"score_spread":0.3055182247321642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}